Synthesis, characterization, anticancer, and antioxidant activity of some new thiazolidin-4-ones in MCF-7 cells

No Thumbnail Available

Date

2013

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

There are limited studies centring on the potential of thiazolidin-4-ones as anticancer agents. In this study, a new series of 2-(3-substituted-1H- pyrazol-4-yl)-3-(3-substituted-5-sulfanyl-1,2,4-triazol-4-yl)-1, 3-thiazolidin-4-one (4a-o) have been synthesized by cyclo-condensation reaction of 5-substituted-4-[(3-substituted-1H-pyrazol-4-ylmethylidene)amino]-2H-1,2,4- triazole-3-thione (3a-o) and thioglycolic acid. The structures of all the synthesized compounds were confirmed by elemental analysis, spectral techniques like IR, 1H NMR, and mass spectroscopy. Few compounds exhibited dose-dependent cytotoxic effect in MTT assay in human breast cancer (MCF-7) cells. Apoptotic degradation of DNA due to action of potent thiazolidin-4-ones was analysed by agarose gel electrophoresis and visualized by ethidium bromide staining (comet assay). A concentration-dependent increase in tail length and olive tail moment was observed when treated with thiazolidin-4-ones. In vitro antioxidant studies like DPPH and ABTS-free radical scavenging assays-indicated moderate activity of thiazolidin-4-ones. © 2012 Springer Science+Business Media, LLC.

Description

Keywords

2 [3 (4 chlorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 (2 tolyloxymethyl) 4h 1,2,4 triazol 4 yl]thiazolidin 4 one, 2 [3 (4 chlorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 (4 tolyloxymethyl) 4h 1,2,4 triazol 4 yl]thiazolidin 4 one, 2 [3 (4 chlorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 (phenoxymethyl) 4h 1,2,4 triazol 4 yl]thiazolidin 4 one, 2 [3 (4 chlorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 [(naphthalen 1 yloxy)methyl] 4h 1,2,4 triazol 4 yl]thiazolidin 4 one, 2 [3 (4 chlorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 [(naphthalen 2 yloxy)] 4h 1,2,4 triazol 4 yl]thiazolidin 4 one, 2 [3 (4 fluorophenyl) 1h pyrazol 4 yl] 3 (3 mercapto 5 (2 tolyloxymethyl) 4h 1,2,4 triazol 4 yl]thiazolidin 4 one, 2 [3 (4 fluorophenyl) 1h pyrazol 4 yl] 3 (3 mercapto 5 (4 tolyloxymethyl) 4H 1,2,4 triazol 4 yl]thiazolidin 4 one, 2 [3 (4 fluorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 (phenoxymethyl) 4h 1,2,4 triazol 4 yl]thiazolidin 4 one, 2 [3 (4 fluorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 [(naphthalen 1yloxy)]methyl] 4h 1,2,4 triazol 4 yl]thiazolidin 4 one, 2 [3 (4 fluorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 [(naphthalen 2 yloxy)methyl] 4h 1,2,4 triazol 4 yl]thiazolidin 4 one, 3 [3 mercapto 5 (2 tolyloxymethyl) 4h 1,2,4 triazol 4 yl] 2 [3 (4 methoxyphenyl) 1h pyrazol 4 yl]thiazolidin 4 one, 3 [3 mercapto 5 (4 tolyloxymethyl) 4h 1,2,4 triazol 4 yl] 2 [3 (4 methoxyphenyl) 1h pyrazol 4 yl]thiazolidin 4 one, 3 [3 mercapto 5 (phenoxymethyl) 4h 1,2,4 triazol 4 yl] 2 [3 (4 methoxyphenyl) 1h pyrazol 4 yl]thiazolidin 4 one, 3 [3 mercapto 5 [(naphthalen 1 yloxy)methyl] 4h 1,2,4 triazol 4 yl] 2 [3 (4 methoxyphenyl) 1h pyrazol 4 yl]thiazolidin 4 one, 3 [3 mercapto 5 [(naphthalen 2 yloxy)methyl] 4h 1,2,4 triazol 4 yl] 2 [3 (4 methoxyphenyl) 1h pyrazol 4 yl]thiazolidin 4 one, antineoplastic agent, antioxidant, ascorbic acid, thiazole derivative, unclassified drug, antineoplastic activity, antioxidant activity, article, breast cancer, cancer cell, concentration response, controlled study, cytotoxicity, DNA fragmentation, drug bioavailability, drug structure, drug synthesis, human, human cell, IC 50, infrared spectroscopy, lipophilicity, mass spectrometry, polymerization, proton nuclear magnetic resonance

Citation

Medicinal Chemistry Research, 2013, 22, 2, pp. 758-767

Collections

Endorsement

Review

Supplemented By

Referenced By